Archive
Proactive news highlights: FairFX, Allergy Therapeutics, SalvaRx, Akers Biosciences, GW Pharma & more
Low-cost currency provider FairFX enjoyed its best ever week last week thanks to heightened trading activity amid the UK’s EU referendum vote.